Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-20 07:33 am Sale | 13G | SINOVAC BIOTECH LTD SVA | Advantech Capital L.P. | 5,851,423 8.16% | -48,577 (-0.82%) | View |
| 2023-12-04 06:01 am Unchanged | 13D | SINOVAC BIOTECH LTD SVA | SAIF Partners IV L.P. | 10,780,820 15.03% | 0 (Unchanged) | View |
| 2023-09-15 08:59 am Unchanged | 13D | SINOVAC BIOTECH LTD SVA | SAIF Partners IV L.P. | 10,780,820 15.03% | 0 (Unchanged) | View |
| 2023-05-25 07:13 am Unchanged | 13D | SINOVAC BIOTECH LTD SVA | SAIF Partners IV L.P. | 10,780,820 15.03% | 0 (Unchanged) | View |
| 2023-03-15 06:01 am Unchanged | 13D | SINOVAC BIOTECH LTD SVA | SAIF Partners IV L.P. | 10,780,820 15.03% | 0 (Unchanged) | View |
| 2022-12-12 06:44 am Unchanged | 13D | SINOVAC BIOTECH LTD SVA | SAIF Partners IV L.P. | 10,780,820 15.03% | 0 (Unchanged) | View |
| 2020-12-22 09:25 am Purchase | 13D | SINOVAC BIOTECH LTD SVA | CDH Fund VI L.P. | 6,000,000 8.44% | 6,000,000 (New Position) | View |
| 2020-12-18 8:53 pm Purchase | 13D | SINOVAC BIOTECH LTD SVA | 1Globe Capital LLC | 18,515,315 32.3% | 9,162,223 (+97.96%) | View |